Weng J, Alizadeh M, Friedman S. Glucagon-Like Peptide-1 Receptor Agonist Therapy Does Not Increase Gastrointestinal Adverse Events in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2025 Aug 19. doi: 10.1007/s10620-025-09344.
PMID: 40830314